FBRX (Forte Biosciences) Moat Score: 2/10 (As of Jul. 08, 2026)


FBRX Forte Biosciences Inc FBRX
34 GF Score
Price $20.56
! 2 Warning Signs
View Full Analysis

What is Forte Biosciences Moat Score?

Forte Biosciences FBRX -7.13% 34 Moat Score is 2 as of Jul. 08, 2026. GuruFocus rates FBRX with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 1,393 Biotechnology companies, Forte Biosciences ranks better than 58.29% on this metric.

Forte Biosciences has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

Forte Biosciences has No Moat: Forte Biosciences Inc is in the early stages of development with limited market presence and no significant intellectual property or regulatory advantages. The biotech industry is highly competitive, and the company lacks the scale, brand strength, and customer loyalty needed for a sustainable moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Forte Biosciences might have No Moat - Very weak/transient advantages.

Forte Biosciences  (NAS:FBRX) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Forte Biosciences Moat Score Related Terms

FBRX vs AUTL, SGMT, BNTC: Moat Score Comparison

For the Biotechnology subindustry, Forte Biosciences's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Forte Biosciences Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Forte Biosciences's Moat Score distribution charts can be found below:

* The bar in red indicates where Forte Biosciences's Moat Score falls into.


FBRX
34GF Score
Forte Biosciences Inc FBRX
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
Forte Biosciences (FBRX) has a Moat Score of 2 as of Jul. 08, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Forte Biosciences ranks #581 out of 1393 companies in the Biotechnology industry, placing it in the top 41.7%.
Is Forte Biosciences' Moat Score too high?
Forte Biosciences' current Moat Score is 2. The Biotechnology industry median Moat Score is 2.00. Forte Biosciences' value of 2 is 0% at this industry median. Based on the distribution chart, Forte Biosciences ranks #581 out of 1393 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Forte Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Forte Biosciences' Moat Score compare to AUTL and SGMT?
According to the Biotechnology industry distribution chart, Forte Biosciences ranks #581 out of 1393 companies for Moat Score. This puts Forte Biosciences in the upper half of its industry. The industry median Moat Score is 2.00. Forte Biosciences' value of 2 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,393 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Forte Biosciences's current Moat Score of 2 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Forte Biosciences's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Forte Biosciences stock overvalued right now?
Forte Biosciences (FBRX) has a current Moat Score of 2. The current Moat Score is 2 and 0% at the Biotechnology industry median of 2.00. Forte Biosciences' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Forte Biosciences (FBRX), the current Moat Score is 2 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Forte Biosciences Business Description

Other Exchanges 37T:Germany
Address 3060 Pegasus Park Drive, Building 6, Dallas, TX, USA, 75247
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
34GF Score

Get the complete analysis for FBRX

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.56
Price